Genomics

Dataset Information

0

Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome

ABSTRACT: Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome

PROVIDER: PRJNA1270095 | ENA |

REPOSITORIES: ENA

Json Xml

Similar Datasets

Genomics NCTN: Risk-Stratified Therapy for Acute Myeloid Leukemia in Down Syndrome (AAML1531)
| PRJNA1270094 | ENA
Genomics NCTN: Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma (ANBL0531)
| PRJNA1288585 | ENA
Genomics NCTN: Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma (ANBL0531)
| PRJNA1288586 | ENA
Genomics NCTN: Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) (AALL1331)
| PRJNA1289253 | ENA
Genomics NCTN: Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL) (AALL1331)
| PRJNA1289254 | ENA
Genomics NCTN: Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL) (AALL0331)
| PRJNA1288572 | ENA
Genomics NCTN: Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL) (AALL0331)
| PRJNA1288571 | ENA
Genomics Down Syndrome
| PRJNA804910 | ENA
Genomics NCTN: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
| PRJNA1288589 | ENA
Genomics NCTN: Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors
| PRJNA1288590 | ENA